Topical a-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?

Схожие документы

• Topical Oxymetazoline Hydrochloride Cream 1% for the Treatment of Persistent Facial Erythema of Rosacea in Adults: A Comprehensive Review of Current Evidence
  по: Del Rosso, James Q., et al.
  Опубликовано: (2021)
• Advances in Understanding and Managing Rosacea: Part 2: The Central Role, Evaluation, and Medical Management of Diffuse and Persistent Facial Erythema of Rosacea
  по: Del Rosso, James Q.
  Опубликовано: (2012)
• The Role of Topical Brimonidine Tartrate Gel as a Novel Therapeutic Option for Persistent Facial Erythema Associated with Rosacea
  по: Johnson, Andrew William, et al.
  Опубликовано: (2015)
• In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea
  по: Piwnica, David, et al.
  Опубликовано: (2018)
• Comments on: “In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea”
  по: Gil, Daniel
  Опубликовано: (2018)